Merck & Co Inc logo

Merck & Co Inc

$ 108.84 +0.39 (+0.36%) 10:08 PM EST
P/E:
18.11
P/B:
6.20
Market Cap:
$ 275.95B
Enterprise V:
$ 294.13B
Volume:
9.35M
Avg Vol (2M):
9.33M
Also Trade In:
Volume:
9.35M
Market Cap $:
275.95B
PE Ratio:
18.11
Avg Vol (2-Month):
9.33M
Enterprise Value $:
294.13B
PB Ratio:
6.20
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Merck & Co Inc ( ) from 1990 to Nov 30 2022. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Merck & stock (MRK) PE ratio as of Nov 30 2022 is 18.11. More Details

Merck & Co Inc (MRK) PE Ratio (TTM) Chart

To
Not Enough Data to Display

Merck & Co Inc (MRK) PE Ratio (TTM) Historical Data

Total 1239
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Merck & PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2022-11-30 18.1 2022-09-26 13.2
2022-11-28 18.0 2022-09-23 13.3
2022-11-25 17.9 2022-09-22 13.4
2022-11-23 17.8 2022-09-21 12.9
2022-11-22 17.8 2022-09-20 13.2
2022-11-21 17.6 2022-09-19 13.3
2022-11-18 17.3 2022-09-16 13.4
2022-11-17 17.0 2022-09-15 13.3
2022-11-16 16.6 2022-09-14 13.3
2022-11-15 16.6 2022-09-13 13.2
2022-11-14 16.7 2022-09-12 13.5
2022-11-11 16.3 2022-09-09 13.4
2022-11-10 16.9 2022-09-08 13.4
2022-11-09 16.9 2022-09-07 13.3
2022-11-08 16.9 2022-09-06 13.2
2022-11-07 16.6 2022-09-02 13.2
2022-11-04 16.5 2022-09-01 13.3
2022-11-03 16.4 2022-08-31 13.1
2022-11-02 16.5 2022-08-30 13.3
2022-11-01 16.6 2022-08-29 13.4
2022-10-31 16.8 2022-08-26 13.7
2022-10-28 16.8 2022-08-25 13.8
2022-10-27 16.6 2022-08-24 13.8
2022-10-26 16.4 2022-08-23 13.8
2022-10-25 16.3 2022-08-22 14.0
2022-10-24 16.2 2022-08-19 14.1
2022-10-21 15.9 2022-08-18 14.0
2022-10-20 15.5 2022-08-17 13.9
2022-10-19 15.5 2022-08-16 13.9
2022-10-18 15.7 2022-08-15 13.9
2022-10-17 15.7 2022-08-12 13.9
2022-10-14 15.3 2022-08-11 13.6
2022-10-13 15.4 2022-08-10 13.7
2022-10-12 15.0 2022-08-09 13.7
2022-10-11 15.2 2022-08-08 13.6
2022-10-10 15.1 2022-08-05 13.4
2022-10-07 14.6 2022-08-04 13.3
2022-10-06 14.6 2022-08-03 13.4
2022-10-05 14.7 2022-08-02 13.4
2022-10-04 14.7 2022-08-01 13.6
2022-10-03 14.6 2022-07-29 13.7
2022-09-30 14.3 2022-07-28 13.8
2022-09-29 14.4 2022-07-27 14.0
2022-09-28 14.4 2022-07-26 14.0
2022-09-27 13.2 2022-07-25 13.9

Merck & Co Inc (MRK) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.